Clinical Trial Update: Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing conventional and hypofractionated IMRT in women with high-risk cervical cancer after radical hysterectomy is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Uterine Cervical Neoplasms | Phase 3 | Status: RECRUITING